CIK 0001818794 · Large accelerated filer
Dyne Therapeutics, Inc.
Sign in to watch- Ticker
- DYN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 364883909
- Phone
- (781) 786-8230
- Business address
- 1560 TRAPELO ROAD, WALTHAM, MA, 02451
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 4 Planned sale CEO & President sold 100,000 shares at an average $28.96 ($2,895,519)
- 4 Planned sale Chief Business Officer sold 28,528 shares at an average $28.46 ($811,865)
- 4 Planned sale SVP, Head of Finance & Admin. sold 12,740 shares at an average $28.05 ($357,296)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 807,838 shares at an average $24.30 ($19,626,903)
- 4 Planned sale 10% owner sold 807,838 shares at an average $24.30 ($19,626,903)
- 144 Insider Sale of Securities
- 4 Planned sale Chief Medical Officer sold 407 shares at $25.00 ($10,175)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
Page 24 of 40 · 796 filings